+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
Healthy Volunteers
ID04669717

Pharmacokinetic Considerations and Dosing Strategies of Amoxicillin and Metronidazole or Azithromycin as Adjunct to Non-surgical Periodontal Therapy. A Randomized, 6-month, Parallel-group Clinical Trial.

Led by University of Geneva, Switzerland · Updated on 2026-04-29

45

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Geneva, Switzerland

Lead Sponsor

U

University of Lausanne

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the use of antibiotics as additional treatments alongside mechanical cleaning for patients with severe periodontitis, an inflammatory disease that damages tooth-supporting tissues and can lead to tooth loss. This trial focuses on how two antibiotic regimensamoxicillin plus metronidazole and azithromycinare absorbed and act in the body to optimize dosage and duration while minimizing risks of antibiotic resistance. The study is a randomized, single-blind clinical trial involving 45 patients over 44 months at the University of Geneva. Participants receive standard mechanical cleaning of their teeth in two appointments, followed by one of three antibiotic treatments amoxicillin plus metronidazole taken three times daily for either 7 days or 3 days, or azithromycin taken once daily for 3 days. Clinical samples such as gingival fluid, saliva, blood, and plaque are collected at various points during and after treatment to measure antibiotic levels and effects on bacteria. The study also monitors safety and adverse events throughout. Throughout the approximately 8-month participation, patients undergo clinical and radiographic exams, sample collection, and follow-up visits at 3 and 6 months to assess bacterial presence and treatment success. Researchers track patient compliance and record any adverse effects. The primary outcome is measuring antibiotic concentrations in bodily fluids at specific days after dosing, while secondary outcomes include changes in bacteria levels, clinical improvements, and safety assessments.

CONDITIONS

Brief Title

Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies

Who Can Participate

Age: 18Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent
  • Age between 18 and 80 years
  • Need for periodontal treatment including adjunctive antibiotic therapy
  • At least 30% of teeth with probing depth greater than 6 mm and bleeding on probing
Not Eligible

You will not qualify if you...

  • Presence of systemic illnesses such as uncontrolled diabetes, cancer, HIV, bone metabolic diseases, or conditions impairing wound healing
  • Pregnancy or breastfeeding
  • Antibiotic use within 2 months prior to the study
  • Current use of nonsteroidal anti-inflammatory drugs
  • Known or suspected intolerance to 5-nitroimidazole derivatives, amoxicillin, or macrolides
  • Periodontal therapy within the last year
  • Known or suspected non-compliance, or history of drug or alcohol abuse
  • Inability to participate due to language barriers, psychological disorders, or dementia
  • Unwillingness to attend regular dental maintenance and follow-up visits
  • Participation in another investigational drug study within 30 days before and during this trial

Research Team

C

Catherine Giannopoulou, Dr med dent

A

Alkisti Zekeridou, Dr med dent

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here